Hi Spade
thanks for your email.
$60m is still a very large market cap for a pre-revenue company with no Line-of-sight of revenue.
Also I don't see to have a great deal of unique IP to justify that price tag.
Let's see - but I think they should do one of two things:
1) Get some novel IP and create a regulatory pathway to a registered pharmaceutical product
2) Create recurring sales
At the moment I see minimal sales and nothing unique about their products.
Thanks
Stephanie
Hi Spadethanks for your email.$60m is still a very large market...
-
- There are more pages in this discussion • 824 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.040(12.5%) |
Mkt cap ! $3.177M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.0¢ | 28.0¢ | $4.691K | 15.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 833 | 1 |
View Market Depth
| Last trade - 15.58pm 28/06/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |